These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31678015)

  • 1. Cystic fibrosis in black African children in South Africa: a case control study.
    Owusu SK; Morrow BM; White D; Klugman S; Vanker A; Gray D; Zampoli M
    J Cyst Fibros; 2020 Jul; 19(4):540-545. PubMed ID: 31678015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic expression of the 3120+1G>A mutation in non-Caucasian children with cystic fibrosis in South Africa.
    Masekela R; Zampoli M; Westwood AT; White DA; Green RJ; Olorunju S; Kwofie-Mensah M
    J Cyst Fibros; 2013 Jul; 12(4):363-6. PubMed ID: 23206872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of CFTR mutations in black cystic fibrosis patients of southern African origin.
    Carles S; Desgeorges M; Goldman A; Thiart R; Guittard C; Kitazos CA; de Ravel TJ; Westwood AT; Claustres M; Ramsay M
    J Med Genet; 1996 Sep; 33(9):802-4. PubMed ID: 8880589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing incidence of cystic fibrosis in Wisconsin, USA.
    Parker-McGill K; Nugent M; Bersie R; Hoffman G; Rock M; Baker M; Farrell PM; Simpson P; Levy H
    Pediatr Pulmonol; 2015 Nov; 50(11):1065-1072. PubMed ID: 26258862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in lung function and nutritional decline in cystic fibrosis by genotype: An analysis of the Canadian cystic fibrosis registry.
    Leung GJ; Cho TJ; Kovesi T; Hamid JS; Radhakrishnan D
    J Cyst Fibros; 2020 Mar; 19(2):255-261. PubMed ID: 31253541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
    Flume PA; Biner RF; Downey DG; Brown C; Jain M; Fischer R; De Boeck K; Sawicki GS; Chang P; Paz-Diaz H; Rubin JL; Yang Y; Hu X; Pasta DJ; Millar SJ; Campbell D; Wang X; Ahluwalia N; Owen CA; Wainwright CE;
    Lancet Respir Med; 2021 Jul; 9(7):733-746. PubMed ID: 33581080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function determinants and mortality of children and adolescents with cystic fibrosis in South Africa 2007-2016.
    Vandenbroucke NJ; Zampoli M; Morrow B
    Pediatr Pulmonol; 2020 Jun; 55(6):1381-1387. PubMed ID: 32176840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome.
    Zampoli M; Verstraete J; Frauendorf M; Kassanjee R; Workman L; Morrow BM; Zar HJ
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34350279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of IVS6A GATT polymorphism of CFTR gene with cystic fibrosis: first study in CF and normal Tunisian population.
    Chaima S; Sondess HF; Khedija B; Ahmed M; Taieb M
    Ann Biol Clin (Paris); 2020 Jun; 78(3):314-318. PubMed ID: 32540817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of cystic fibrosis in South Africa.
    Goldman A; Labrum R; Claustres M; Desgeorges M; Guittard C; Wallace A; Ramsay M
    Clin Genet; 2001 Jan; 59(1):37-41. PubMed ID: 11168023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in cystic fibrosis survival over 40 years in South Africa: An observational cohort study.
    Zampoli M; Kassanjee R; Verstraete J; Westwood A; Zar HJ; Morrow BM
    Pediatr Pulmonol; 2022 Apr; 57(4):908-918. PubMed ID: 34967140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial - preliminary results.
    Murer C; Huber LC; Kurowski T; Hirt A; Robinson CA; Bürgi U; Benden C
    Swiss Med Wkly; 2018; 148():w14593. PubMed ID: 29451946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
    Davies JC; Moskowitz SM; Brown C; Horsley A; Mall MA; McKone EF; Plant BJ; Prais D; Ramsey BW; Taylor-Cousar JL; Tullis E; Uluer A; McKee CM; Robertson S; Shilling RA; Simard C; Van Goor F; Waltz D; Xuan F; Young T; Rowe SM;
    N Engl J Med; 2018 Oct; 379(17):1599-1611. PubMed ID: 30334693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
    Keating D; Marigowda G; Burr L; Daines C; Mall MA; McKone EF; Ramsey BW; Rowe SM; Sass LA; Tullis E; McKee CM; Moskowitz SM; Robertson S; Savage J; Simard C; Van Goor F; Waltz D; Xuan F; Young T; Taylor-Cousar JL;
    N Engl J Med; 2018 Oct; 379(17):1612-1620. PubMed ID: 30334692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype patterns for mutations of the cystic fibrosis transmembrane conductance regulator gene: a retrospective descriptive study from Saudi Arabia.
    Banjar HH; Tuleimat L; El Seoudi AAA; Mogarri I; Alhaider S; Nizami IY; AlMaghamsi T; Alkaf SA; Moghrabi N
    Ann Saudi Med; 2020; 40(1):15-24. PubMed ID: 32026723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy.
    Terlizzi V; Di Lullo AM; Comegna M; Centrone C; Pelo E; Castaldo G; Raia V; Braggion C
    Ital J Pediatr; 2018 Jan; 44(1):2. PubMed ID: 29298718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.